Biolargo Inc (BLGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,103 | 2,777 | 3,269 | 3,654 | 4,351 |
| Cost of Goods | 731 | 1,356 | 1,781 | 1,906 | 2,629 |
| Gross Profit | 372 | 1,421 | 1,488 | 1,748 | 1,722 |
| Operating Expenses | 8,283 | 3,579 | 4,131 | 4,271 | 3,412 |
| Operating Income | -7,180 | -1,802 | -1,862 | -1,617 | -1,061 |
| Interest Expense | 144 | 80 | 65 | 6 | 13 |
| Other Income | 80 | 0 | 6 | -109 | 14 |
| Pre-tax Income | -7,244 | -1,882 | -1,921 | -1,732 | -1,060 |
| Net Income Continuous | -7,244 | -1,882 | -1,921 | -1,732 | -1,060 |
| Minority Interests | -765 | -690 | -766 | -718 | -523 |
| Net Income | $-6,479 | $-1,192 | $-1,155 | $-1,014 | $-537 |
| EPS Basic Total Ops | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 |
| EBITDA(a) | $-7,038 | $-1,666 | $-1,765 | $-1,550 | $-993 |